APA (7th ed.) Citation

Cox, T. M., Drelichman, G., Cravo, R., Balwani, M., Burrow, T. A., Martins, A. M., . . . Peterschmitt, M. J. (2017). Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy. Blood, 129(17), 2375. https://doi.org/10.1182/blood-2016-12-758409

Chicago Style (17th ed.) Citation

Cox, Timothy M., et al. "Eliglustat Maintains Long-term Clinical Stability in Patients with Gaucher Disease Type 1 Stabilized on Enzyme Therapy." Blood 129, no. 17 (2017): 2375. https://doi.org/10.1182/blood-2016-12-758409.

MLA (9th ed.) Citation

Cox, Timothy M., et al. "Eliglustat Maintains Long-term Clinical Stability in Patients with Gaucher Disease Type 1 Stabilized on Enzyme Therapy." Blood, vol. 129, no. 17, 2017, p. 2375, https://doi.org/10.1182/blood-2016-12-758409.